Form 10-Q REXAHN PHARMACEUTICALS, For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. SPY
9. BE
10. IVBIY

Go back to Form 10-Q REXAHN PHARMACEUTICALS, For: Sep 30

Rexahn Pharma (RNN) Posts Narrower than Expected Q3 Loss of 1c/Share

November 13, 2014 7:44 AM EST

Rexahn Pharma (AMEX: RNN) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02).

The company ended the quarter with about $35.59 million in cash.

September 30, 2014 December 31, 2013 ASSETS Current Assets: Cash and cash equivalents $14,971,660 $18,688,031 Marketable securities (note 3) 20,613,885 100,000

For earnings history and earnings-related data on Rexahn Pharma (RNN) click here.

... More